OXN Oxonica

RNS Number:1884P
Oxonica plc
03 March 2008






                     Oxonica launches OptisolTM Sun Defence


Oxonica plc ("Oxonica"), a leading international nanomaterials group, is pleased
to announce, ahead of the 2008 summer season, the launch of OptisolTM Sun
Defence at the Professional Beauty Show held in London on March 2nd to the 4th.
This new fully-formulated high performance SPF25 sun cream is designed to
protect the skin against sun damage, providing long lasting photostable UVA and
UVB protection.



The formulation contains OptisolTM UV absorber a product originally invented at
the University of Oxford.  Although OptisolTM Sun Defence will not be the first
or only fully formulated skin product to contain OptisolTM UV absorber it
represents the first sun care product marketed directly to consumers by Oxonica.
  The product will initially be available, via the Oxonica website and is
expected to be available through specialist outlets in the UK in due course.



The benefits of OptisolTM Sun Defence formulation include:



*   Ingredients including antioxidants and free radical inhibitors which
    help combat premature ageing of the skin

*   Unique natural skin tone formula which provides additional protection
    against the sun's most penetrating rays and promotes natural radiance



OptisolTM Sun Defence is targeted initially at the UK premium sun care market
which has an estimated market size of �35 million.  The product is, however,
registered for sale across Europe.



For all trade enquiries please call 01865 856719 or visit
www.optisolsundefence.com.





For further information, please contact:



Oxonica plc                               01865 856 728
Kevin Matthews, Chief Executive
Richard Clarke, Finance Director



The Broadcast PR Business                 0207 812 6624
Matthew Locke


Notes to Editors



About Oxonica plc - www.oxonica.com



Oxonica (AIM: OXN.L) is one of the leading international nanomaterials groups
with products already launched into international markets and is listed in
London on the AIM market. It was spun-out from Oxford University in 1999.
Oxonica's mission is to focus on the development of innovative commercial
solutions for international markets using its expertise in the design and
application of nanomaterials. It owns a portfolio of demand driven products that
offer substantial benefits to the target markets of energy, materials, security
and diagnostics.



The Group currently has four operating businesses: Oxonica Energy, Oxonica
Materials, Oxonica Security and Oxonica Diagnostics.  Oxonica has already
launched products into international markets.  Lead products include:

*   EnviroxTM fuel borne catalyst - a nanocatalyst improving
    fuel economy and reducing emissions

*   OptisolTM UV absorber - a revolutionary photostable UV
    protection system designed to optimise the performance of quality sunscreens 
    and anti-premature aging products



Oxonica is also active in searching for the next generation of products and is
already engaged in developing transformational detection technologies which will
enable a new generation of ultra-sensitive multiplex diagnostic tools for the
clinical diagnostic life science and security markets. In addition, Oxonica is
developing other UV absorber technologies into polymer systems and coatings,
based on similar technologies to that used in OptisolTM.








                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

PRLFXLFBVXBFBBX

Oxonica (LSE:OXN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Oxonica (LSE:OXN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024